Jared A. Gollob
AdvisorDr. Jared A. Gollob, M.D., had been the Chief Medical Officer at Kymera Therapeutics, Inc. since September 20, 2018 until July 27, 2026 and will continue providing services to the Company as an advisor until December 31, 2026. Dr. Gollob served as Vice President of Clinical Research at Alnylam Pharmaceuticals, Inc. from June 27, 2012 to September 2018. Prior to joining Alnylam, Dr. Gollob held academic positions at Harvard Medical School and Duke University School of Medicine and was on staff at Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center and Duke University Medical Center, where he was engaged in both clinical and laboratory research in oncology and immunology Dr. Gollob was Vice President of Clinical Development and Global Vice President of Medical Affairs for Amyloidosis from June 2012 to August 2018. Dr. Gollob joined Alnylam in 2007 and is responsible for management of the clinical development organization and program leadership role for Alnylam 's ALN-VSP program. Dr. Gollob served as Senior Director of Clinical Research of Alnylam Pharmaceuticals, Inc. since October 2007 until May 2012. Prior to Alnylam, he served at Duke University where he was Associate Professor of Medicine and Director of the Biologic Therapy Program, with a secondary appointment as Associate Professor of Immunology. He also served as Head of Hematology/Oncology at the Duke VA Medical Center. Jared is a board certified Medical Oncologist with interests in the immunotherapy of cancer, specifically renal cell carcinoma and melanoma. Previously, he has advised Chiron, Schering-Plough, Bayer and Novartis on their oncology programs. He received his B.A. and M.D. from Columbia University and then completed his clinical training in internal medicine and medical oncology at Massachusetts General Hospital and the Dana-Farber Cancer Institute, respectively. Dr. Gollob has authored more than 50 peer-reviewed papers published in top-tier medical and scientific journals.
Positions
- Company NameKymera Therapeutics, Inc.Stock CodeKYMRPositionAdvisorColleagues
- NMNello MainolfiCo-Founder, President, CEO & Director
- FJFelix James BakerIndependent Chairman
- BNBruce N. JacobsChief Financial Officer
- BRBrian R. AdamsChief Legal Officer & Corporate Secretary
- NGNoah GoodmanChief Business Officer
- JWJeffrey W. AlbersIndependent Director
- PEPamela EspositoIndependent Director
- EHElena H. RidloffIndependent Director
